Literature DB >> 25096655

Community-acquired multidrug-resistant Gram-negative bacterial infective endocarditis.

Sowjanya Naha1, Kushal Naha1, Vasudev Acharya1, H Manjunath Hande1, G Vivek2.   

Abstract

We describe two cases of bacterial endocarditis secondary to multidrug-resistant Gram-negative organisms. In both cases, the diagnosis was made in accordance with the modified Duke's criteria and confirmed by histopathological analysis. Furthermore, in both instances there were no identifiable sources of bacteraemia and no history of contact with hospital or other medical services prior to the onset of symptoms. The patients were managed in similar fashion with prolonged broad-spectrum antibiotic therapy and surgical intervention and made complete recoveries. These cases highlight Gram-negative organisms as potential agents for endocarditis, as well as expose the dissemination of such multidrug-resistant bacteria into the community. The application of an integrated medical and surgical approach and therapeutic dilemmas encountered in managing these cases are described. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25096655      PMCID: PMC4127679          DOI: 10.1136/bcr-2014-204176

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Gram-negative endocarditis.

Authors:  Milagros P Reyes; Katherine C Reyes
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.725

2.  Diagnosis of E. coli tricuspid valve endocarditis: a case report.

Authors:  Takahiko Tsutsumi; Eiji Hiraoka; Kenji Kanazawa; Hozuka Akita; Lawrence J Eron
Journal:  Hawaii Med J       Date:  2010-12

Review 3.  Clinical practice. Infective endocarditis.

Authors:  Bruno Hoen; Xavier Duval
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245

Review 4.  Management of Gram-negative and fungal endocarditis.

Authors:  Emanuele Durante-Mangoni; Marie-Françoise Tripodi; Rosina Albisinni; Riccardo Utili
Journal:  Int J Antimicrob Agents       Date:  2010-12-03       Impact factor: 5.283

Review 5.  Escherichia coli endocarditis: seven new cases in adults and review of the literature.

Authors:  S Branger; J P Casalta; G Habib; F Collard; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

6.  Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Ann F Bolger; Matthew E Levison; Patricia Ferrieri; Michael A Gerber; Lloyd Y Tani; Michael H Gewitz; David C Tong; James M Steckelberg; Robert S Baltimore; Stanford T Shulman; Jane C Burns; Donald A Falace; Jane W Newburger; Thomas J Pallasch; Masato Takahashi; Kathryn A Taubert
Journal:  Circulation       Date:  2005-06-14       Impact factor: 29.690

7.  Resurgence of Pseudomonas endocarditis in Detroit, 2006-2008.

Authors:  Milagros P Reyes; Ammar Ali; Rodrigo E Mendes; Douglas J Biedenbach
Journal:  Medicine (Baltimore)       Date:  2009-09       Impact factor: 1.889

8.  Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa.

Authors:  M P Reyes; A M Lerner
Journal:  Rev Infect Dis       Date:  1983 Mar-Apr

9.  Non-HACEK gram-negative bacillus endocarditis.

Authors:  Susan Morpeth; David Murdoch; Christopher H Cabell; Adolf W Karchmer; Paul Pappas; Donald Levine; Francisco Nacinovich; Pierre Tattevin; Núria Fernández-Hidalgo; Stuart Dickerman; Emilio Bouza; Ana del Río; Tatjana Lejko-Zupanc; Auristela de Oliveira Ramos; Diana Iarussi; John Klein; Catherine Chirouze; Roger Bedimo; G Ralph Corey; Vance G Fowler
Journal:  Ann Intern Med       Date:  2007-12-18       Impact factor: 25.391

10.  Native valve Escherichia coli endocarditis following urosepsis.

Authors:  D Rangarajan; S Ramakrishnan; K C Patro; S Devaraj; V Krishnamurthy; Y Kothari; N Satyaki
Journal:  Indian J Nephrol       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.